Somatostatin analogues for treatment of enterocutaneous fistula
- 30 April 2013
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 4
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Enterocutaneous Fistulas in the Setting of Trauma and Critical IllnessClinics in Colon and Rectal Surgery, 2010
- Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane reviewHPB, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Nutrition and management of enterocutaneous fistulaBritish Journal of Surgery, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Surgical management of intestinal failureProceedings of the Nutrition Society, 2003
- Inhibition of Pancreatic Secretion under Long-Term Octreotide Treatment in HumansDigestion, 1994
- Treatment of 27 Postoperative Enterocutaneous Fistulas with the Long Half-life Somatostatin Analogue SMS 201–995Annals of Surgery, 1989
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982